List of Figures
List of Tables
List of Abbreviations
Foreword by Andrea Mantovani
Acknowledgements
Preface
About the Author
Introduction
Part A The Challenges of Drug Pricing and Market Access
1 Why is drug pricing different? 2 The Age of Value and Affordability
3 The Access Journey
4 Fair Pricing
Part B Traveling the Access Journey
5 Payers
6 Medical Community
7 Provider Organizations
8 Patients
Part C Pricing and Payer Management Techniques
9 Fundamentals of Pricing
10 Reference-Based Pricing
11 Health Economics and Outcomes Research
12 Attributes
Benefits
Value and Price
Part D Structured Access and Pricing Approaches
13 Pricing and Drug Development
14 Payer Segmentation
15 The PODiUM Framework
16 BEST Framework
17 Development Options and Decisions
18 Value Story and Messaging
Part E Developing an Integrated Global Strategy
19 Developing a Global Pricing Strategy
20 Public Policy
21 Oncology and Orphan Drugs
22 Gene Therapy Pricing and Funding
23 Biosimilars
24 Payer and Pricing Research
Part F Access and Pricing Strategy Implementation
25 Organizing for Access
26 Access and Price Negotiations
27 Value-based Agreements
28 Creating Win-Win Deals
Part G Key Health Care Systems
29 United States
30 Canada
31 France
32 Germany
33 Italy
34 Spain
35 United Kingdom
36 Japan
37 Australia
38 Brazil
39 China
40 India
41 South Korea
References
Index